Cortechs.ai Raises Series C Funding Round

Cortechs.ai Raises Series C Funding Round

Cortechs.ai, a San Diego, CA-based AI-powered neuroimaging and prostate imaging solutions, has raised Series C funding.

The round was led by VILAS Ventures, with participation from existing investor Genting Berhad and a diverse group of backers.

VILAS Ventures is a healthcare-focused investment firm dedicated to driving transformative healthcare innovations. The firm provides both capital and extensive operational support to its portfolio companies.

The funds will fuel product expansion, commercialization, and research and development, positioning Cortechs.ai as a global leader in AI-driven clinical decision support.

Cortechs.ai specializes in AI-powered medical imaging solutions for neuroimaging and prostate imaging. Its innovative tools leverage AI to enhance diagnostic confidence, improve patient outcomes, and support clinicians in diagnosing and monitoring complex medical conditions. Cortechs.ai's flagship products include NeuroQuant®, which plays a critical role in early diagnosis and monitoring of neurodegenerative diseases such as Alzheimer's, and OnQ Prostate, a fast-growing tool aiding prostate cancer detection.

Funding Details

Company: Cortechs.ai

Raised: Undisclosed

Round: Series C

Funding Date: November 2024

Lead Investor: VILAS Ventures

Additional Investors: Genting Berhad, others

Company Website: https://www.cortechs.ai/

Software Category: Medical Imaging Solutions